NCT01711502已完成不适用
Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A Retrospective Cohort Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 128
- 试验地点
- 15
- 主要终点
- The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage
研究概览
简要总结
This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.
详细描述
Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female aged 18 years and over Diagnosis of breast cancer according to ICD-10 diagnostic criteria with confirmed metastasis
- •Confirmed diagnosis between 1st July 2010 - 30th June 2011
- •Female patient managed for her disease at the same setting where final diagnosis of MBC was performed
排除标准
- •History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer)
结局指标
主要结局
The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage
时间窗: At 12 and 18 months after diagnosis
次要结局
- The progression free survival (PFS) rates(At 12 and 18 months after diagnosis)
- The progression free survival (PFS) time(At 18 months after diagnosis)
- Time to progression (TTP)(At 18 months after diagnosis)
- The clinical and pathological characteristics of newly diagnosed MBC patients(At 18 months after diagnosis)
- The socio-demographic and anthropometric characteristics of newly diagnosed MBC patients(At 18 months after diagnosis)
- Health care utilization associated with the disease in Romania(At 18 months after diagnosis)
研究者
研究点 (15)
Loading locations...
相似试验
招募中
不适用
Longitudinal Study of Local Ablative Therapy in Oligometastatic DiseaseOligometastatic DiseaseMetastasesAblation TechniquesRadiotherapyStereotactic RadiationSurgeryNCT06356779Gitte Fredberg Persson MD PhD1,200
已完成
不适用
Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)Metastatic Colorectal CancerNCT02612077Hoffmann-La Roche765
已完成
不适用
This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in KoreaCOPDNCT01419379Takeda1,118
招募中
不适用
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinibMetastatic Renal Cell CarcinomaNCT06548867Gruppo Oncologico Italiano di Ricerca Clinica80
已完成
不适用
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment StudyUrothelial CarcinomaNCT06412848Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany360